Affordable Access

Exploring the idiotypes of insulin antibodies as markers for remission in Type 1 diabetes.

Authors
Type
Published Article
Journal
Diabetic medicine : a journal of the British Diabetic Association
Publication Date
Volume
21
Issue
12
Pages
1316–1324
Identifiers
PMID: 15569135
Source
Medline

Abstract

We have established the principle of using phage display in the investigation of insulin antibodies during remission in Type 1 diabetes. The immunological characteristics of IA 3 months after the introduction of insulin treatment were different from those at diagnosis of Type 1 diabetes (IAA). Using phage display technology, it was not possible to distinguish insulin antibodies according to remission status.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments